169 results on '"Talhari, S"'
Search Results
2. Lobomykose Erfolgreiche Therapie mit Clofazimin und Itrakonazol bei einem 46-jährigen Patienten nach 32-jähriger Krankheitsdauer: Erfolgreiche Therapie mit Clofazimin und Itrakonazol bei einem 46-jährigen Patienten nach 32-jähriger Krankheitsdauer
3. Diffuses Infiltrat der Ohrmuschel bei einem 59-jährigen Brasilianer
4. Lobomycosis: an emerging disease in humans and delphinidae
5. Immunophenotype of skin lymphocytic infiltrate in patients co-infected with Mycobacterium leprae and human immunodeficiency virus: a scenario dependent on CD8+ and/or CD20+ cells
6. Research Article E6 and E7 gene sequences of human papillomavirus type 13 isolated from a young native girl from the Brazilian Amazon
7. Hautulkus bei Histoplasmose und HIV-Infektion
8. Advances in paracoccidioidomycosis
9. Nicht venerische Treponematosen: AKS14/13
10. Geographical dermatology: INV 17
11. The evaluation of three standard treatment schedules for cutaneous leishmaniasis in Suriname and Brazil with the Quantitative Nucleic Acid Sequence-Based Amplification (QT-NASBA) assay
12. Cutaneous larva migrans: rapid improvement of clinical pathology after treatment with ivermectin
13. Effects of intradermal gamma-interferon in cutaneous leishmaniasis
14. P3.255 Trichomonas Vaginalis and Associated Factors Among Women Living with HIV/AIDS in Amazonas, Brazil
15. Serial quantitative PCR assay for detection, species-discrimination and quantification of Leishmania spp. in human samples
16. P1-S5.24 Prevalence ofChlamydia trachomatisamong women infected by HIV attending the institute of tropical medicine in Amazonas, Brazil
17. P3-S7.06 Vaginal discharge in women living with HIV attending an AIDS clinic in Manaus, Brazil
18. Identification of fungemia agents using the polymerase chain reaction and restriction fragment length polymorphism analysis
19. Advances in paracoccidioidomycosis
20. International Issues: Meningoencephalitis due to Paracoccidioides brasiliensis
21. Leprosy and HIV Coinfection: A Clinical, Pathological, Immunological, and Therapeutic Study of a Cohort from a Brazilian Referral Center for Infectious Diseases.
22. Secondary dapsone-resistant leprosy in Brazil: a preliminary report
23. A study of leprosy and other skin diseases in school children in the state of Amazonas, Brazil
24. Secondary dapsone-resistant leprosy in Brazil: a preliminary report
25. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
26. Pre- and post-surgical evaluation of the impact on Hansen disease sequealae patients' quality of life submitted to orthopedic surgery for closure of chronic plantar ulcers.
27. Treatment of cutaneous leishmaniasis with a sequential scheme of pentamidine and tamoxifen in an area with a predominance of Leishmania (Viannia) guyanensis: A randomised, non-inferiority clinical trial.
28. Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme.
29. Leprosy post-exposure prophylaxis risks not adequately assessed.
30. Anais Brasileiros de Dermatologia: 2016-2020 Administration. Actions and acknowledgements.
31. Main etiological agents identified in 170 men with urethritis attended at the Fundação Alfredo da Matta, Manaus, Amazonas, Brazil.
32. Atypical manifestations of recent syphilis: study of 19 cases.
33. A Single Haplotype of IFNG Correlating With Low Circulating Levels of Interferon-γ Is Associated With Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis.
34. Millipede accident with unusual dermatological lesion.
35. A polymorphism in the IL1B gene (rs16944 T/C) is associated with cutaneous leishmaniasis caused by Leishmania guyanensis and plasma cytokine interleukin receptor antagonist.
36. Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil.
37. Changes in the Brazilian Annals of Dermatology. Unpostponable initiatives.
38. Thanks and reply from the editors of the ABD to the comments on the correspondence sent to heads of services accredited by SBD.
39. Reply of the authors of the Continuing Medical Education article to Dr. Jaison Barreto and Dr. Laila Laguiche.
40. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
41. Case for diagnosis. Atypical genital lesion.
42. Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.
43. New perspectives for the treatment of Hansen's disease.
44. Changes in sight.
45. New Year.
46. Sustained Presence of Cutaneous Leishmaniasis in Urban Manaus, the Largest Human Settlement in the Amazon.
47. Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study.
48. High-risk human papillomavirus and cervical lesions among women living with HIV/AIDS in Brazilian Amazon, Brazil.
49. Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil.
50. A historical overview of leprosy epidemiology and control activities in Amazonas, Brazil.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.